比利时软件和3D打印服务提供商Materialise（纳斯达克股票代码：MTLS）透露，在2020年财务业绩中，其30年历史的收入下降了第一年。
During FY 2020, the company generated €170 million in revenue, 13% less than the €197 million reported in FY 2019. Even though Materialise’s revenue recovered slightly between Q3 and Q4 2020, turning over a total of €45 million, this figure still represents an 11% reduction compared to the €51 million reported in Q4 2019.
While Materialise’s Medical income increased substantially during the fourth quarter, it didn’t grow sufficiently to offset the 16% revenue drops seen within its Manufacturing and Software divisions. Interestingly, in spite of the firm’s overall revenue decline, investors have chosen to focus on its quarterly recovery, and the company’s shares rose by over 24% in early morning trading.
在与分析师和投资者的收益电话中，Mitalize的执行董事长彼得·莱斯（Peter Leys）强调，该公司最近的复苏为重新恢复增长奠定了基础。Leys评论说：“ Covid-19- 1920年的流行使2020年成为全球经济的极具挑战性的一年，而且这是Mitalize 30年历史上的第一次，收入逐年下降。”
“While uncertainty remains, we are encouraged by the fact that our fourth quarter 2020 revenues grew double digits sequentially,” he added. “We also believe that our continued R&D efforts and strategic investments position us well to expand our existing business, and capture new growth opportunities.”
Materialise’s Q4 2020 financials
Materialise’s revenue is reported across three main segments: Software, Medical, and Manufacturing. Although the company’s Manufacturing division remained its highest earner, accounting for 39% of the firm’s total revenue, it still declined during Q4 2020, falling from the €21 million generated in Q4 2019 to €18 million.
According to Leys, Materialise’s Manufacturing segment continued to suffer at the close of 2020, due to the reluctance of its clients to spend during the pandemic. However, the firm’s acquisition of footwear scanning companyRSSCAN在第四季度的过程中，确实产生了762,000欧元，预计将贡献更多。
Software-wise, Materialise’s revenue also dropped by 16% between Q4 2019 and Q4 2020, falling from €12 million to €10 million. Despite a 40% increase in quarterly sales, and a 3.5% jump in recurring revenue, the company saw less Software activity from its 3D printing base during Q4, with many holding back due to financial difficulties.
Contrastingly, Medical was the firm’s best performing segment during Q4 2020, remaining flat compared to Q4 2019, but growing by 1.5% across FY 2020. The company’s healthcare revenue was reinforced by the acquisition ofEngimplanin August last year, while its clinical software achieved a 30% increase in sales between Q3 and Q4 2020.
In terms of the company’s operating costs, it made cutbacks due to COVID-19 but didn’t sack any employees or cut R&D spending, continuing to re-invest 14.5% of its revenue during Q4. Thanks to its shrewd spending strategy, Materialise has been able to offer an increased EBITDA margin of 16.3% for the quarter, somewhat explaining why investors have viewed the firm’s financial results so favorably.
| 收入（€） | Q4 2019 | Q4 2020 | 差异（％） | 2019财年 | 2020财年 | 差异（％） |
| Software | 12m | 10m | -16 | 42m | 39m | -7 |
| Medical | 17m | 17m | N/A。 | 61m | 62m | +1 |
| Manufacturing | 21m | 18m | -14 | 94m | 70m | -26 |
| Total | 51m | 45m | -11 | 197m | 170m | -12 |
Switching to a cloud trajectory
Although Materialise’s revenue broadly fell during FY 2020, it did achieve notable successes over the year, especially within its eyewear and software verticals. The firmlaunched its mindware offeringin August 2020, a consultancy service tailored to the needs of its business clients, and the company is developing a new cloud-based program for launch in H2 2021.
As part of the revamp, Materialise is also modernizing its legacy software, and according to Leys, the firm has begun to “completely redesign” its portfolio, after identifying a customer trend towards cloud-based computing. “It’s obvious that the COVID-19 crisis has accelerated digitization in general, and cloud-based services in particular,” explained Leys.
“All of our medical OEM partners are taking advantage of our cloud-based services, and that’s why we have already started a complete redesign of the legacy materialise software,” he added. “During 2020, we came close to a full transformation of our software technology base into cloud-compatible APIs, making them ideal building blocks for the future.”
在其他地方，物质期望同上的战略投资在2021年支付股息，并预计其临床收入也会增加。在收入电话会议上，莱斯重申了这一点，他说，由于其解决方案的“中断”，因此，当Covid-19退后将“继续增长”，因此该公司的医疗部门将“继续增长”。
Materialise focuses on short-term
During Q1 2021, Materialise has made it clear that it expects its Software and Medical segments to continue recovering, generating revenues similar to those seen in Q1 2020. However, the firm also anticipates difficulties for its Manufacturing division, meaning that it has forecast a 5 to 10% annual revenue decline for the quarter.
Similarly, Materialise has seen inconsistent uptake from its automotive and aerospace clients over Q4 2020, making it difficult for the company to speculate on its future earnings. As a result, the firm has refused to issue guidance for Q2 2021 and beyond, claiming that it remains well-positioned for the future, but uncertain about the pandemic’s future direction.
Leys总结道：“目前，我们的前景还不够成熟，在我们的各个部门和地区都过于多样化，无法提供定量指导。”“根据我们的战略，我们将继续投资于我们的研发计划和内部基础设施，这将使我们在2021年的整体业绩重视。”
To stay up to date with the latest 3D printing news, don’t forget to subscribe to the3D打印行业通讯or follow us on推特or liking our page onFacebook。
您是否正在寻找添加剂制造业的工作？访问3D打印作业在行业中选择一系列角色。
特色图片显示，有人在如何使用Mitalize的Magics软件上进行了辅导。通过物质照片照片。
